Clover Biopharmaceuticals, Ltd. (HKG:2197)
Hong Kong
· Delayed Price · Currency is HKD 0.2090
+0.0030 (1.46%)
Apr 25, 2025, 3:57 PM HKT
Clover Biopharmaceuticals Revenue
In the year 2024, Clover Biopharmaceuticals had annual revenue of 38.42M CNY, down -2.13%. Clover Biopharmaceuticals had revenue of 48.52M in the half year ending December 31, 2024.
Revenue
38.42M CNY
Revenue Growth
-2.13%
P/S Ratio
6.63
Revenue / Employee
99.27K CNY
Employees
387
Market Cap
271.09M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Alibaba Health Information Technology | 31.39B |
| Sino Biopharmaceutical | 30.72B |